| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |